Featured Post

Twenty Practical Steps to Better Corporate Governance | The Corporate Secretaries International Association (CSIA)

Twenty Practical Steps to Better Corporate Governance | The Corporate Secretaries International Association (CSIA) Please click the li...

Sunday, June 11, 2017

Is the FDA a Big Risk to This Company’s Marijuana Plans?

http://ift.tt/2rd29z1

business-person-worried-gettyimages-4745

Insys Therapeutics NASDAQ INSY 160 might have a problem on its hands This week the FDA requested that Endo International NASDAQ ENDP remove its opioid medication Opana ER from the market and that news raises the question Who s next If Insys Therapeutics

June 11, 2017 at 12:01PM

http://ift.tt/2t8DvMd

from

http://ift.tt/2t8DvMd


No comments:

Post a Comment